We invite all Global COVID-19 Summit participants to join us in aligning around the global targets and taking the associated required actions to end the COVID-19 pandemic and build back better. These global targets and associated actions by governments, international institutions, and the private sector are drawn from those targets set out by the Multilateral Leaders Task Force on COVID-19, the Access to COVID-19 Tools (ACT)-Accelerator, the G20, the G7, and members of multiple expert commissions.
Tag: COVID-19
Requiring Coronavirus Disease 2019 Vaccination for Federal Employees-Executive Order -09/09/2021
Each agency shall implement, to the extent consistent with applicable law, a program to require COVID-19 vaccination for all of its Federal employees, with exceptions only as required by law. The Task Force shall issue guidance within 7 days of the date of this order on agency implementation of this requirement for all agencies covered by this order.
Death due to COVID-19 vaccination in India
The number of deaths reported following COVID-19 vaccination in the country is only 0.0002% of 23.5 crore doses administered which is within the expected death rates in a population. In a population, deaths occur at a certain rate.
21 जून से देश के हर राज्य में सभी नागरिकों के लिए भारत सरकार मुफ्त वैक्सीन मुहैया कराएगी-PM Modi-07/06/2021
राज्य सरकारों को छूट क्यों नहीं दी जा रही? राज्य सरकारों को लॉकडाउन की छूट क्यों नहीं मिल रही? One Size Does Not Fit All जैसी बातें भी कही गईं। दलील ये दी गई कि संविधान में चूंकि Health-आरोग्य, प्रमुख रूप से राज्य का विषय है, इसलिए अच्छा है कि ये सब राज्य ही करें। इसलिए इस दिशा में एक शुरूआत की गई। भारत सरकार ने एक बृहद गाइडलाइन बनाकर राज्यों को दी ताकि राज्य अपनी आवश्यकता और सुविधा के अनुसार काम कर सकें। स्थानीय स्तर पर कोरोना कर्फ्यू लगाना हो, माइक्रो कन्टेनमेंट जोन बनाना हो, इलाज से जुड़ी व्यवस्थाएं हो, भारत सरकार ने राज्यों की इन मांगों को स्वीकार किया।
Japan gifted to Taiwan 1.24 million doses of AstraZeneca covid vaccine for free-China said OK
Epidemic prevention and control is the most important task and people's lives should be given top priority. I would like to advise the Taiwan authorities to focus on scientific epidemic prevention and control, remove man-made political obstacles, and ensure that the lives, health, interests and well-being of our Taiwan compatriots are effectively protected.
China opposes politicization of virus origin-tracing by US politicians
I would like to reiterate that origin-tracing is a scientific issue. On this issue concerning the health and safety of humanity, we should stay true to the original aspiration of saving lives and getting better prepared to cope with similar public health crisis in the future. We should embark on the path of unity and cooperation instead of instigating confrontation and division. We should rely on science rather than political manipulation. Any attempt to politicize the origin-tracing issue is neither moral nor popular, and will only end in failure.
Anti-COVID-19 2-DG drug developed by DRDO was researched by Patanjali-Read the Original Research Paper
The 2-DG derivative formed a hydrogen bond with the glutamine amino acid residues of the viral spike glycoprotein. The present in silico study supports the potential benefits of using 2-DG and its glucopyranose derivative as repurposed drugs/prodrugs for mitigating the novel COVID-19 infection. Since both these moieties present no signs of serious toxicity, further empirical studies on model systems and human clinical trials to ascertain effective dose-response are warranted and should be urgently initiated.
BRYONIA patient complains loss of smell, inflammatory trouble, pneumonia or pleurisy
The Bryonia breathing is panting and very rapid, little short rapid breaths, due to the fact that deep breathing increases the pain; the Bryonia patient desires to breathe deep, wants deep breathing, needs deep breathing, but it hurts him so. "Constant disposition to sigh," but cannot because it hurts him so. Shortness of breath, suffocation, asthma. Asthmatic attacks from becoming overheated. Asthma worse in a warm room, wants cool air to breathe.
WHO commends U.S support for temporary waiver on IP rights for COVID-19 vaccines-05/05/2021
On Wednesday, Ambassador Tai issued a statement saying the extraordinary circumstances caused by the COVID-19 pandemic required extraordinary measures to respond and that the waiving of intellectual property protections on vaccines was needed to help end the pandemic. The United States would, the statement continued, participate in World Trade Organization negotiations to support the temporary waiving of protections, and work with the private sector and other partners to expand vaccine manufacturing and distribution.
Claims linking 5G technology with COVID-19 pandemic are false and have no scientific basis
It has come to the notice of the Department of Telecommunications (DoT), Ministry of Communications that several misleading messages are being circulated on various social media platforms claiming that the second wave of coronavirus has been caused by the testing of the 5G mobile towers. As per a press statement issued by DoT these messages are false and absolutely not correct. The press statement informs that the general public is hereby informed that there is no link between 5G technology and spread of COVID-19 and they are urged not to be misguided by the false information and rumours spread in this matter.
DCGI approves anti-COVID drug developed by DRDO for emergency use
An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Dictionary of Influenza illness
An influenza pandemic is a global outbreak of a new influenza A virus. Pandemics happen when new (novel) influenza A viruses emerge which are able to infect people easily and spread from person to person in an efficient and sustained way. In the spring of 2009, a novel influenza A (H1N1) virus emerged. It was detected first in the United States and spread quickly across the United States and the world. This new H1N1 virus contained a unique combination of influenza genes not previously identified in animals or people. It should be noted that influenza virus testing is not required to make a clinical diagnosis of influenza in outpatients with suspected influenza, particularly during increased influenza activity when seasonal influenza A and B viruses are circulating in the local community.
